Summary: Background: Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with COVID-19.
Erica A. Voss +63 more
doaj +1 more source
Core Concepts in Pharmacoepidemiology: Multi-Database Distributed Data Networks. [PDF]
ABSTRACT Multi‐database distributed data networks for post‐marketing surveillance of drug safety and effectiveness use two main approaches: common data models (CDMs) and common protocols. Networks such as the U.S. Sentinel System, the Observational Health Data Sciences and Informatics (OHDSI) network, and the Data Analysis and Real‐World Interrogation ...
Haber R +8 more
europepmc +2 more sources
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System (FAERS) to RxNorm and Anatomical Therapeutic Chemical (ATC) Codes. [PDF]
ABSTRACT Purpose The Food and Drug Administration Adverse Event Reporting System (FAERS) is an important source of information on suspected adverse drug reactions, but does not standardise drugs. The Adverse Event Open Learning Through Universal Standardization (AEOLUS) System Provides Standardisation of drugs in FAERS to RxNorm, but its coverage ...
Parry RE +5 more
europepmc +2 more sources
BackgroundElectronic health records (EHRs, such as those created by an anesthesia management system) generate a large amount of data that can notably be reused for clinical audits and scientific research. The sharing of these data
Antoine Lamer +7 more
doaj +1 more source
ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model [PDF]
Supplementing the Spontaneous Reporting System (SRS) with Electronic Health Record (EHR) data for adverse drug reaction detection could augment sample size, increase population heterogeneity and cross-validate results for pharmacovigilance research. The difference in the underlying data structures and terminologies between SRS and EHR data presents ...
Yue, Yu +6 more
openaire +2 more sources
Dermatologic Research Potential of the Observational Health Data Sciences and Informatics (OHDSI) Network [PDF]
<b><i>Background:</i></b> The Observational Health Data Sciences and Informatics (OHDSI) network enables access to billions of deidentified, standardized health records and built-in analytics software for observational health research, with numerous potential applications to dermatology.
Torunn Elise Sivesind +4 more
openaire +2 more sources
Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Among Type 2 Diabetes Patients: Replication and Reliability Assessment Across a Research Network. [PDF]
ABSTRACT Introduction The aim of this study is to use observational methods to evaluate reliability of evidence generated by a study of the effect of glucagon‐like peptide 1 receptor agonists (GLP‐1RA) on chronic lower respiratory disease (CLRD) outcomes among Type‐2 diabetes mellitus (T2DM) patients.
Conover MM +6 more
europepmc +2 more sources
Characterizing treatment pathways at scale using the OHDSI network [PDF]
Observational research promises to complement experimental research by providing large, diverse populations that would be infeasible for an experiment. Observational research can test its own clinical hypotheses, and observational studies also can contribute to the design of experiments and inform the generalizability of experimental research ...
Hripcsak, G. +16 more
openaire +5 more sources
OHDSI Germany – Join the Journey: A Workshop
The Observational Health Data Science and Informatics (OHDSI) is an international collaboration that enables researchers to conduct observational studies around the globe based on standardized data and methods that was founded in 2014 [ref:1]. OHDSI provides a common data model (OMOP CDM) [for full text, please go to the a.m. URL]
Reinecke, I +5 more
openaire +2 more sources
Applicability Assessment of Technologies for Predictive and Prescriptive Analytics of Nephrology Big Data. [PDF]
ABSTRACT The integration of big data into nephrology research will open new avenues for analyzing and understanding complex biological datasets, driving advances in personalized management of kidney diseases. This paper describes the multifaceted challenges and opportunities by incorporating big data in nephrology, emphasizing the importance of data ...
Stojanov R +12 more
europepmc +2 more sources

